Locations
San Francisco, CA, USA
industry
Biotechnology · DeepTech
Size
1 - 10 employees
Stage
Other
founded in
2023
Granza Bio is a biotechnology company developing a novel delivery “shell” platform to direct therapeutic cargo to specific tissues. For their lead candidate, Granza Bio is leveraging the discovery of the immune system’s powerful suite of weapons, “attack particles”. Utilizing their advanced delivery platform, they aim to target these "attack particles" against a range of diseases such as cancer, autoimmune disorders, and infections.
Something looks off?